Elizabeth Ralevski, PhD
Research Scientist in PsychiatryCards
Appointments
Psychiatry
Primary
Contact Info
Psychiatry
300 George St
New Haven, CT 06511-
United States
About
Copy Link
Titles
Research Scientist in Psychiatry
Biography
Dr. Ralevski is an Assistant Professor of Psychiatry at Yale University School of Medicine and the Project Director for the Substance Abuse Treatment Program. Dr. Ralevski completed her Post Doctoral Fellowship at Harvard Medical School. She joined the faculty at Yale University in 2001. Her research interest include the search for appropriate treatment for individuals with dual diagnosis of alcoholism and other psychiatric conditions including depression, post traumatic stress disorder, schizophrenia and borderline personality disorder. Her other research examines factors, such as stress, that may lead to the development and maintenance of alcoholism and other mental disorders.
Last Updated on May 26, 2024.
Appointments
Psychiatry
Research ScientistPrimary
Other Departments & Organizations
- Alcoholism Treatment Center
- Connecticut Mental Health Center
- Division of Addictions
- Psychiatry
- Psychology Section
- VA Alcohol Research Center
- Yale Ventures
Education & Training
- PhD
- York University (2000)
Research
Copy Link
Overview
Stress Reactivity in Veterans Receiving Pharmacological Treatment for PTSD and Alcohol Dependence
Medical Research Interests
Alcoholism; Comorbidity; Diagnosis, Dual (Psychiatry); Personality; Personality Disorders; Pharmacology; Psychiatry; Stress, Physiological
ORCID
0000-0003-0144-4079
Research at a Glance
Yale Co-Authors
Frequent collaborators of Elizabeth Ralevski's published research.
Publications Timeline
A big-picture view of Elizabeth Ralevski's research output by year.
Research Interests
Research topics Elizabeth Ralevski is interested in exploring.
Ismene Petrakis, MD
Jane Jane, PhD
Erin O'Brien, PsyD
Gihyun Yoon, MD
Jenelle Newcomb
John Krystal, MD
12Publications
281Citations
Alcoholism
Comorbidity
Personality Disorders
Diagnosis, Dual (Psychiatry)
Publications
2025
Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial
Yoon G, Pittman B, Ralevski E, Petrakis I, Krystal J. Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial. The International Journal Of Neuropsychopharmacology 2025, 28: pyaf056. PMID: 40795937, PMCID: PMC12395335, DOI: 10.1093/ijnp/pyaf056.Peer-Reviewed Original ResearchCitationsAltmetric
2024
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine
Petrakis I, Meshberg‐Cohen S, Nich C, Kelly M, Claudio T, Jane J, Pisani E, Ralevski E. Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine. American Journal On Addictions 2024, 33: 525-533. PMID: 38624259, DOI: 10.1111/ajad.13557.Peer-Reviewed Original ResearchCitationsAltmetricThe role of neurosteroids in posttraumatic stress disorder and alcohol use disorder: A review of 10 years of clinical literature and treatment implications
Peltier M, Verplaetse T, Altemus M, Zakiniaeiz Y, Ralevski E, Mineur Y, Gueorguieva R, Picciotto M, Cosgrove K, Petrakis I, McKee S. The role of neurosteroids in posttraumatic stress disorder and alcohol use disorder: A review of 10 years of clinical literature and treatment implications. Frontiers In Neuroendocrinology 2024, 73: 101119. PMID: 38184208, PMCID: PMC11185997, DOI: 10.1016/j.yfrne.2023.101119.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
2023
Progesterone Attenuates the Stress Response in Individuals with Alcohol Dependence and Post-Traumatic Stress Disorder – A Pilot Study
Ralevski E, Newcomb J, Pisani E, DeNegre D, Peltier M, Jane J, Yoon G, Petrakis I. Progesterone Attenuates the Stress Response in Individuals with Alcohol Dependence and Post-Traumatic Stress Disorder – A Pilot Study. Journal Of Dual Diagnosis 2023, 20: 39-51. PMID: 38147491, PMCID: PMC11214330, DOI: 10.1080/15504263.2023.2294989.Peer-Reviewed Original ResearchCitationsAltmetric
2012
Treatment for Comorbid Borderline Personality Disorder and Alcohol Use Disorders: A Review of the Evidence and Future Recommendations
Gianoli MO, Jane JS, O'Brien E, Ralevski E. Treatment for Comorbid Borderline Personality Disorder and Alcohol Use Disorders: A Review of the Evidence and Future Recommendations. Experimental And Clinical Psychopharmacology 2012, 20: 333-344. PMID: 22686496, PMCID: PMC3697118, DOI: 10.1037/a0027999.Peer-Reviewed Original ResearchCitationsAltmetricSubjective Effects of Thiopental in Young Adults with and without a Family History of Alcoholism
Petrakis IL, Kerfoot K, Pittman B, Perrino A, Koretski J, Newcomb J, Limoncelli D, Acampora G, Ralevski E. Subjective Effects of Thiopental in Young Adults with and without a Family History of Alcoholism. Journal Of Addiction Research & Therapy 2012, 2013: 6336. PMID: 24273687, PMCID: PMC3835602, DOI: 10.4172/2155-6105.s7-002.Peer-Reviewed Original ResearchCitationsCognitive deficits in schizophrenia and alcoholism: A review of the evidence and findings on the effects of pharmacological treatments on cognitive functioning in patients with dual diagnoses
Ralevski E, Gianoli MO, Russo, M, Dwan, R, Radhakrishnan, R. Cognitive deficits in schizophrenia and alcoholism: A review of the evidence and findings on the effects of pharmacological treatments on cognitive functioning in patients with dual diagnoses. Journal of Dual Diagnosis 2012, 8(3): 205-217. doi:10.1080/15504263.2012.696534Peer-Reviewed Original Research
2011
Preliminary Findings on the Interactive Effects of IV Ethanol and IV Nicotine on Human Behavior and Cognition: A Laboratory Study
Ralevski E, Perry EB, D’Souza D, Bufis V, Elander J, Limoncelli D, Vendetti M, Dean E, Cooper TB, McKee S, Petrakis I. Preliminary Findings on the Interactive Effects of IV Ethanol and IV Nicotine on Human Behavior and Cognition: A Laboratory Study. Nicotine & Tobacco Research 2011, 14: 596-606. PMID: 22180582, PMCID: PMC6281082, DOI: 10.1093/ntr/ntr258.Peer-Reviewed Original ResearchCitationsAltmetricNoradrenergic vs Serotonergic Antidepressant with or without Naltrexone for Veterans with PTSD and Comorbid Alcohol Dependence
Petrakis IL, Ralevski E, Desai N, Trevisan L, Gueorguieva R, Rounsaville B, Krystal JH. Noradrenergic vs Serotonergic Antidepressant with or without Naltrexone for Veterans with PTSD and Comorbid Alcohol Dependence. Neuropsychopharmacology 2011, 37: 996-1004. PMID: 22089316, PMCID: PMC3280636, DOI: 10.1038/npp.2011.283.Peer-Reviewed Original ResearchCitationsAltmetricEffects of Acamprosate on Cognition in a Treatment Study of Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence
Ralevski E, O'Brien E, Jane JS, Dean E, Dwan R, Petrakis I. Effects of Acamprosate on Cognition in a Treatment Study of Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence. The Journal Of Nervous And Mental Disease 2011, 199: 499-505. PMID: 21716064, DOI: 10.1097/nmd.0b013e3182214297.Peer-Reviewed Original ResearchCitationsAltmetric
Get In Touch
Copy Link
Contacts
Mailing Address
Psychiatry
300 George St
New Haven, CT 06511-
United States